Stryker (SYK) Cash from Investing Activities (2009 - 2026)

Stryker (SYK) reported Cash from Investing Activities of -$185.0 million for Q1 2026, up 95.53% year-over-year from -$94.6 million in Q1 2025, and up 39.34% quarter-over-quarter from -$305.0 million in Q4 2025.

Stryker (SYK) Cash from Investing Activities (2009 - 2026) Analysis & Trends

Stryker (SYK) has 18 years of Cash from Investing Activities data on file, last reported at -$185.0 million in Q1 2026.

  • Cash from Investing Activities for Q1 2026 came in at -$185.0 million, up 95.53% year-over-year; the trailing twelve-month figure through Mar 2026 was -$915.0 million (up 86.4% YoY), and the FY2025 annual result was -$4.9 billion, down 62.2% from the prior year.
  • Cash from Investing Activities rose to -$185.0 million in Q1 2026 per SYK's latest filing, from -$305.0 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $72.0 million in Q3 2022 and troughed at -$4.1 billion in Q1 2025.
  • A 5-year average of -$702.2 million and a median of -$185.0 million in 2026 frame the typical range for Cash from Investing Activities.
  • On a YoY basis, Cash from Investing Activities climbed as much as 129.15% in 2022 and fell as far as 2693.75% in 2022.
  • A 5-year view of Cash from Investing Activities shows it stood at -$162.0 million in 2022, then climbed by 6.17% to -$152.0 million in 2023, then tumbled by 99.34% to -$303.0 million in 2024, then decreased by 0.66% to -$305.0 million in 2025, then surged by 39.34% to -$185.0 million in 2026.
  • Business Quant data shows SYK's Cash from Investing Activities at -$185.0 million in Q1 2026, -$305.0 million in Q4 2025, and -$321.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -20.32 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -185.00 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -816.00 Mn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -92.80 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -475.32 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -298.50 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -2.50 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -217.20 Mn
10 Zimmer Biomet Holdings 17.18 Bn 16.77 Bn 1.51 Bn -159.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -185.00 Mn
Mar 31, 2026 -185.00 Mn
Dec 31, 2025 -305.00 Mn
Dec 31, 2025 -305.00 Mn
Sep 30, 2025 -321.00 Mn
Sep 30, 2025 -321.00 Mn
Jun 30, 2025 -104.00 Mn
Jun 30, 2025 -104.00 Mn
Mar 31, 2025 -4.14 Bn
Mar 31, 2025 -4.14 Bn
Dec 31, 2024 -303.00 Mn
Dec 31, 2024 -303.00 Mn
Sep 30, 2024 -2.17 Bn
Sep 30, 2024 -2.17 Bn
Jun 30, 2024 -117.00 Mn
Jun 30, 2024 -117.00 Mn
Mar 31, 2024 -408.00 Mn
Mar 31, 2024 -408.00 Mn
Dec 31, 2023 -152.00 Mn
Dec 31, 2023 -152.00 Mn